| A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and … WC Miller, IF Hoffman, BS Hanscom, TV Ha, K Dumchev, Z Djoerban, ... The Lancet 392 (10149), 747-759, 2018 | 100 | 2018 |
| Benefits and potential harms of human immunodeficiency virus self-testing among men who have sex with men in China: an implementation perspective Y Qin, W Tang, A Nowacki, K Mollan, SA Reifeis, MG Hudgens, NS Wong, ... Sexually transmitted diseases 44 (4), 233-238, 2017 | 52 | 2017 |
| Assessing the impact of AGS-004, a dendritic cell-based immunotherapy, and vorinostat on persistent HIV-1 Infection CL Gay, JD Kuruc, SD Falcinelli, JA Warren, SA Reifeis, JL Kirchherr, ... Scientific Reports 10 (1), 5134, 2020 | 48 | 2020 |
| On variance of the treatment effect in the treated when estimated by inverse probability weighting SA Reifeis, MG Hudgens American Journal of Epidemiology 191 (6), 1092-1097, 2022 | 26 | 2022 |
| Financial incentives for adherence to hepatitis C virus clinical care and treatment: a randomized trial of two strategies DA Wohl, AG Allmon, D Evon, C Hurt, SA Reifeis, H Thirumurthy, B Straub, ... Open forum infectious diseases 4 (2), ofx095, 2017 | 25 | 2017 |
| Regional differences between people who inject drugs in an HIV prevention trial integrating treatment and prevention (HPTN 074): a baseline analysis KE Lancaster, IF Hoffman, B Hanscom, TV Ha, K Dumchev, H Susami, ... Journal of the International AIDS Society 21 (10), e25195, 2018 | 20 | 2018 |
| Precise and accurate power of the rank-sum test for a continuous outcome KR Mollan, IM Trumble, SA Reifeis, O Ferrer, CP Bay, PL Baldoni, ... Journal of biopharmaceutical statistics 30 (4), 639-648, 2020 | 19 | 2020 |
| Exact power of the rank-sum test for a continuous variable KR Mollan, IM Trumble, SA Reifeis, O Ferrer, CP Bay, PL Baldoni, ... arXiv preprint arXiv:1901.04597, 2019 | 14 | 2019 |
| Assessing exposure effects on gene expression SA Reifeis, MG Hudgens, M Civelek, KL Mohlke, MI Love Genetic epidemiology 44 (6), 601-610, 2020 | 7 | 2020 |
| Depressive symptoms and use of HIV care and medication-assisted treatment among people with HIV who inject drugs O Zeziulin, KR Mollan, BE Shook-Sa, B Hanscom, KE Lancaster, ... Aids 35 (3), 495-501, 2021 | 5 | 2021 |
| Engaging people who inject drugs living with HIV in antiretroviral treatment and medication for opioid use disorder: extended follow-up of HIV Prevention Trials Network (HPTN) 074 KE Lancaster, KR Mollan, BS Hanscom, BE Shook-Sa, TV Ha, ... Open Forum Infectious Diseases 8 (8), ofab281, 2021 | 2 | 2021 |
| Financial Payments for Participating in Research while Incarcerated: Attitudes of Prisoners R Divya, PP Christopher, EJ Filene, SA Reifeis, BL White IRB: Ethics & Human Research 40 (6), 1-6, 2018 | 2 | 2018 |
| Causal Inference for Observational Genomics Data SA Reifeis The University of North Carolina at Chapel Hill, 2020 | 1 | 2020 |
| Assessing Etiologic Heterogeneity for Multinomial Outcome with Two-Phase Outcome-Dependent Sampling Design SA Reifeis, MG Hudgens, MA Troester, MI Love medRxiv, 2022.07. 20.22277805, 2022 | | 2022 |
| Financial Payments for Participating in Research while Incarcerated D Ravi, PP Christopher, EJ Filene, SA Reifeis, BL White IRB: Ethics & Human Research 40 (6), 1-6, 2018 | | 2018 |
| Regional differences between people who inject drugs in an HIV prevention trial integrating treatment and prevention KE Lancaster, IF Hoffman, B Hanscom, T Viet Ha, K Dumchev, H Susami, ... Regional differences between people who inject drugs in an HIV prevention …, 0 | | |
